Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
Return to: PBR Home | Production & Manufacturing | Manufacturing


EMA's CHMP backs Novartis' Zykadia for first-line use in lung cancer By PBR Staff Writer
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended approval to expand the use of Novartis' Zykadia (ceritinib) in anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC).
Production & Manufacturing > Manufacturing > News
ReNeuron secures £1.8m grant to optimize cell therapy manufacturing processes Innovate UK has awarded ReNeuron Group a £1.8m grant to further advance its next generation commercial cell therapy manufacturing capabilities.
Production & Manufacturing > Manufacturing > News FDA accepts to review Pfizer’s sNDA for XELJANZ to treat adult PsA patients The US Food and Drug Administration (FDA) has accepted for review Pfizer's supplemental New Drug Application (sNDA) for XELJANZ (tofacitinib citrate) 5 mg twice daily (BID) for the treatment of adult patients with active psoriatic arthritis (PsA).
Production & Manufacturing > Manufacturing > News
See more Manufacturing news

Latest Manufacturing News and Insight